Light-Controlled Toxicity of Engineered Amyloid β-Peptides

Aggregation of amyloid β (Aβ1–42), causing toxicity, is a critical step in Alzheimer's disease (AD). AD studies are difficult to compare because Aβ1–42 aggregation is poorly controllable under physiological conditions. To control aggregation and toxicity, we engineered light‐switchable Aβ1–42 a...

Full description

Saved in:
Bibliographic Details
Published inChembiochem : a European journal of chemical biology Vol. 13; no. 18; pp. 2657 - 2660
Main Authors Hoppmann, Christian, Barucker, Christian, Lorenz, Dorothea, Multhaup, Gerd, Beyermann, Michael
Format Journal Article
LanguageEnglish
Published Weinheim WILEY-VCH Verlag 21.12.2012
WILEY‐VCH Verlag
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aggregation of amyloid β (Aβ1–42), causing toxicity, is a critical step in Alzheimer's disease (AD). AD studies are difficult to compare because Aβ1–42 aggregation is poorly controllable under physiological conditions. To control aggregation and toxicity, we engineered light‐switchable Aβ1–42 analogues that enable controllable conversion of nontoxic fibrils into toxic oligomers simply by illumination.
Bibliography:istex:626D17EAF99F728F0632EC3117A339D11362354F
ark:/67375/WNG-RHKCHSB6-Z
ArticleID:CBIC201200605
ISSN:1439-4227
1439-7633
DOI:10.1002/cbic.201200605